As early as nine weeks, the MaterniT 21 PLUS test screens for both common and rare chromosomal abnormalities that can affect your baby’s health.

MaterniT® 21 PLUS offers insights into your baby’s health as early as nine weeks int...
See More o your pregnancy. The pioneering NIPT is safe, accurate, and has been used by more than 600,000 women to date.

The MaterniT® 21 PLUS test can screen for certain chromosomal abnormalities that could affect your baby’s health and development, providing you with more information earlier in your pregnancy.​ Test results are typically returned in about five days from the receipt of your blood draw at our lab in California.

*MaterniT® and Sequenom are now part of Integrated Genetics, a member of LabCorp’s Specialty Testing Group. Integrated Genetics offers a broad menu of genetic testing options, including non-invasive prenatal testing (NIPT), carrier screening and hereditary cancer screening. To learn more, please visit: www.integratedgenetics.com or www.sequenom.com.